| Patents for C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media (9,992) |
|---|
| 01/13/2005 | WO2005003303A2 Nadks as modifiers of branching morphogenesis and methods of use |
| 01/13/2005 | WO2005003302A2 Novel methods to modulate mast cells |
| 01/13/2005 | WO2005003301A2 Methods, compositions, and kits for predicting the effect of compounds on hot flash symptoms |
| 01/13/2005 | WO2005003300A2 Tissue scaffold having aligned fibrils, apparatus and method for producing same, and methods of using same |
| 01/13/2005 | WO2005003299A2 Polynucleotides encoding novel guanylate binding proteins (gbp's) |
| 01/13/2005 | WO2005003297A2 Mptens as modifiers of the pten/igf pathway and methods of use |
| 01/13/2005 | WO2005003296A2 Albumin fusion proteins |
| 01/13/2005 | WO2005003295A2 Methods and compositions for maturing dendritic cells utilizing inosine-containing compounds |
| 01/13/2005 | WO2005003294A2 Unnatural reactive amino acid genetic code additions |
| 01/13/2005 | WO2005003293A2 pRNA CHIMERA |
| 01/13/2005 | WO2005003292A2 Composition and method for self-assembly and mineralization of peptide amphiphiles |
| 01/13/2005 | WO2005003291A2 Bead bound combinatorial oligonucleoside phosphorothioate and phosphorodithioate aptamer libraries |
| 01/13/2005 | WO2005003290A2 Methods and devices for determining a cell characteristic, and applications employing same |
| 01/13/2005 | WO2005003289A2 Ap1 amine oxidase variants |
| 01/13/2005 | WO2005003288A2 Diagnostic methods , prognostic methods and pharmaceutical compositions for neurodegenerative diseases like alzheimer’s disease by modulating and investigating genes rgs4 and itpkb, their gene products or fragments and derivatives thereof |
| 01/13/2005 | WO2005002418A2 Mptens as modifiers of the pten/igf pathway and methods of use |
| 01/13/2005 | WO2004094605A8 Methods and compositions for inhibiting stat signaling pathways |
| 01/13/2005 | WO2004087880A8 Compounds and their use to treat diabetes and related disorders |
| 01/13/2005 | WO2004078943A3 Alternative heterocycles for dna recognition |
| 01/13/2005 | WO2004044135A3 Structural motifs and oligomeric compounds and their use in gene modulation |
| 01/13/2005 | WO2004044131A3 Cross-linked oligomeric compounds and their use in gene modulation |
| 01/13/2005 | US20050009771 Methods and systems for identifying naturally occurring antisense transcripts and methods, kits and arrays utilizing same |
| 01/13/2005 | US20050009178 Matrix comprised of biopolymer fibers for use in propagation and culturing of tissues; tissue engineering and regenerative medicine; tissue grafting; prosthetics |
| 01/13/2005 | US20050009168 Methods and apparatus for Adeno associated virus purification |
| 01/13/2005 | US20050009150 Humanized antibodies that recognize beta amyloid peptide |
| 01/13/2005 | US20050009111 Identifying modulators which decrease or prevent arrestin transport across membranes; g-protein coupled protein modulators; identifying drug treatments for cardiovascular, inflammatory and respiratory disorders |
| 01/13/2005 | US20050009066 Methods for localizing target molecules in a flowing fluid sample |
| 01/13/2005 | US20050009049 Expanding the eukaryotic genetic code |
| 01/13/2005 | US20050009031 Allelic nucleotide sequences coding human kinesin-like protein 1(KLSN1) and insulin degrading enzyme (IDE) as diagnostic tool in diagnosis/pronosis of nervous system disorders |
| 01/13/2005 | US20050008625 Antibody affinity engineering by serial epitope-guided complementarity replacement |
| 01/13/2005 | US20050008618 Composition for delivering an agent to a target cell and uses thereof |
| 01/13/2005 | US20050008572 Biocompatibility; sustained release |
| 01/13/2005 | CA2749227A1 Bead bound combinatorial oligonucleoside phosphorothioate and phosphorodithioate aptamer libraries |
| 01/13/2005 | CA2563362A1 Methods and compositions for maturing dendritic cells utilizing inosine-containing compounds |
| 01/13/2005 | CA2531360A1 Methods of producing differentiated hematopoietic cells for treatment of cytopenia |
| 01/13/2005 | CA2531321A1 Rna processing protein complexes and uses thereof |
| 01/13/2005 | CA2531123A1 Assay and process for labeling and detection of micro rna and small interfering rna sequences |
| 01/13/2005 | CA2530530A1 Methods and compositions for enhanced protein expression and purification |
| 01/13/2005 | CA2529403A1 Glucanases, nucleic acids encoding them and methods for making and using them |
| 01/13/2005 | CA2528134A1 Tissue scaffold having aligned fibrils, apparatus and method for producing the same, and artificial tissue and methods of use thereof |
| 01/13/2005 | CA2528084A1 Sppls as modifiers of the p53 pathway and methods of use |
| 01/13/2005 | CA2527908A1 Mylks as modifiers of branching morphogenesis and methods of use |
| 01/13/2005 | CA2527905A1 Nadks as modifiers of branching morphogenesis and methods of use |
| 01/13/2005 | CA2527877A1 Unnatural reactive amino acid genetic code additions |
| 01/13/2005 | CA2527853A1 Mptens as modifiers of the pten/igf pathway and methods of use |
| 01/13/2005 | CA2527089A1 Acyltransferases for alteration of polyunsaturated fatty acids and oil content in oleaginous yeasts |
| 01/13/2005 | CA2526896A1 Glyceraldehyde-3-phosphate dehydrogenase and phosphoglycerate mutase promoters for gene expression in oleaginous yeast |
| 01/13/2005 | CA2524148A1 Mptens as modifiers of the pten/igf pathway and methods of use |
| 01/13/2005 | CA2518716A1 Inhibition of viral pathogenesis |
| 01/13/2005 | CA2513213A1 Albumin fusion proteins |
| 01/13/2005 | CA2510653A1 Prna chimera |
| 01/13/2005 | CA2502610A1 Bead bound combinatorial oligonucleoside phosphorothioate and phosphorodithioate aptamer libraries |
| 01/13/2005 | CA2494798A1 Ap1 amine oxidase variants |
| 01/12/2005 | EP1495122A1 Antiviral therapy on the basis of rna interference |
| 01/12/2005 | EP1495118A2 High level expression of immunogenic proteins in the plastids of higher plants |
| 01/12/2005 | EP1495116A1 Saccharomyces cerevisiae yeast strain with improved phytase activity |
| 01/06/2005 | WO2005001065A2 Variant humicola grisea cbh1.1 |
| 01/06/2005 | WO2005001063A2 Polynucleotides capable of target-dependent circularization and topological linkage |
| 01/06/2005 | WO2005001062A2 Modified vectors for organelle transfection |
| 01/06/2005 | WO2005001061A2 Polynucleotides encoding novel adiponectin receptor variants |
| 01/06/2005 | WO2005001060A2 Novel calcium channel |
| 01/06/2005 | WO2005001059A2 Inactivating organisms using carbon dioxide at or near its supercritical pressure and temperature conditions |
| 01/06/2005 | WO2005001058A2 Identification of biomarkers for liver toxicity |
| 01/06/2005 | WO2005001057A2 Lactobacillus acidophilus nucleic acids encoding fructo-oligosaccharide utilization compounds and uses thereof |
| 01/06/2005 | WO2005001056A2 Methods for controlling catalase |
| 01/06/2005 | WO2005001055A2 Stabilized immunomodulatory oligonucleotides |
| 01/06/2005 | WO2005001053A2 Method of inhibiting receptor tyrosine kinases with an extracellular antagonist and an intracellular antagonist |
| 01/06/2005 | WO2005001052A2 Modulation of apoptosis |
| 01/06/2005 | WO2005001051A2 Compositions and methods for regulating polysaccharides of a plant cell |
| 01/06/2005 | WO2005001050A2 Transcription factors |
| 01/06/2005 | WO2005001049A2 Compositions, splice variants and methods relating to ovarian specific genes and proteins |
| 01/06/2005 | WO2005001047A2 N-carbobenzyloxy (n-cbz)-deprotecting enzyme and uses therefor |
| 01/06/2005 | WO2005001046A2 Methods for predicting the course of a malignant disease |
| 01/06/2005 | WO2005001045A2 Materials and methods for production of fruit-free, pollen-free plants with large showy flowers |
| 01/06/2005 | WO2005001044A2 Compositions related to pleiotrophin methods and uses thereof |
| 01/06/2005 | WO2005001043A2 METHODS AND COMPOSITIONS FOR ENHANCING THE EFFICACY AND SPECIFICITY OF FNAi |
| 01/06/2005 | WO2005001040A2 Non-lethal conditioning methods for conditioning a recipient for bone marrow transplantation |
| 01/06/2005 | WO2005001039A2 Ribozyme-regulated small inhibitory rna (sirna) production and methods of use thereof |
| 01/06/2005 | WO2005001038A2 Recombinant anti-cd30 antibodies and uses thereof |
| 01/06/2005 | WO2005001037A2 Electrolyte membranes based on alkyloxysilane grafted thermoplastic polymers |
| 01/06/2005 | WO2005001036A2 Novel trichoderma genes |
| 01/06/2005 | WO2005001035A2 Ladder copolymers |
| 01/06/2005 | WO2005001034A2 Rna-exit-channel: target and method for inhibition of bacterial rna polymerase |
| 01/06/2005 | WO2005001032A2 Fine mapping of chromosome 17 quantitative trait loci and use of same for marker assisted selection |
| 01/06/2005 | WO2005001031A2 Modulation of the rna interference pathway |
| 01/06/2005 | WO2005001030A2 Markers for pre-cancer and cancer cells and the method to interfere with cell proliferation therein |
| 01/06/2005 | WO2005001026A2 Adks as modifiers of the pten pathway and methods of use |
| 01/06/2005 | WO2005001025A2 Immunoglobulin chimeric monomer-dimer hybrids |
| 01/06/2005 | WO2005001023A2 Method and carrier complexes for delivering molecules to cells |
| 01/06/2005 | WO2005001022A2 Methods and compositions for enhancing immune response |
| 01/06/2005 | WO2005001021A2 Nanocarpets for trapping particulates, bacteria and spores |
| 01/06/2005 | WO2005001020A2 A multi-stage open ion system in various topologies |
| 01/06/2005 | WO2005000087A2 Gene products differentially expressed in cancerous colon cells and their methods of use ii |
| 01/06/2005 | WO2004085622A3 Network-enabled software logic providing discovery and configuration of network appliances coupled to a lan |
| 01/06/2005 | WO2004078906A3 Method for producing a immobilised virus carrier and the use thereof |
| 01/06/2005 | WO2004061076A3 Method and apparatus for determining gene expression levels |
| 01/06/2005 | US20050005318 Using micromanipulation and microtubule inhibitors to enucleate oocytes; generating cloned animal embryos for use in treatment and prevention nervous sytem disorders and heart disease; in vitro fertilization |
| 01/06/2005 | US20050004024 Methods of treating Pin1 associated disorders by covalent modification of active site residues |
| 01/06/2005 | US20050004008 Determining metastatic of cancer using concentration of phosphorylated adaptor protein; anticancer agenst |
| 01/06/2005 | US20050003510 Transgenic lactobacillus which has been modified to express heterologous gene products on cell wall surface for use as therapeutic tool in prevention of bacterial infection and inflammatory response |